KP Tissue (TSE:KPT) Stock Price Expected to Rise, TD Analyst Says

KP Tissue (TSE:KPT) had its price target increased by investment analysts at TD from C$12.00 to C$14.00 in a report issued on Tuesday,BayStreet.CA reports. The brokerage currently has a “hold” rating on the stock. TD’s price target would suggest a potential upside of 8.11% from the stock’s previous close.

Separately, Desjardins raised their price objective on shares of KP Tissue from C$12.00 to C$12.50 and gave the company a “hold” rating in a research report on Friday, May 15th. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of C$12.12.

KP Tissue Stock Down 0.4%

Shares of KPT stock traded down C$0.05 during trading on Tuesday, hitting C$12.95. The company had a trading volume of 12,947 shares, compared to its average volume of 15,757. The stock’s 50-day moving average is C$12.56 and its two-hundred day moving average is C$11.35. The stock has a market capitalization of C$129.86 million, a price-to-earnings ratio of 14.39, a price-to-earnings-growth ratio of -0.88 and a beta of 0.53. KP Tissue has a 52 week low of C$8.77 and a 52 week high of C$13.78.

KP Tissue (TSE:KPT) last announced its earnings results on Thursday, May 14th. The company reported C$0.22 earnings per share (EPS) for the quarter. On average, research analysts predict that KP Tissue will post 0.4398964 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director David A. Spraley sold 3,668 shares of the business’s stock in a transaction that occurred on Wednesday, June 17th. The stock was sold at an average price of C$13.30, for a total value of C$48,784.40. Following the completion of the sale, the director owned 15,712 shares in the company, valued at C$208,969.60. The trade was a 18.93% decrease in their position. In the last ninety days, insiders sold 6,668 shares of company stock valued at $87,644. Insiders own 0.14% of the company’s stock.

About KP Tissue

KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.